Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

Rationale: The coronavirus disease (COVID-19) pandemic struck an immunologically naive, globally interconnected population. In the face of a new infectious agent causing acute respiratory failure for which there were no known effective therapies, rapid, often pragmatic trials were necessary to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Samuel M., Peltan, Ithan, Kumar, Naresh, Leither, Lindsay, Webb, Brandon J., Starr, Nathan, Grissom, Colin K., Buckel, Whitney R., Srivastava, Rajendu, Butler, Allison M., Groat, Danielle, Haaland, Benjamin, Ying, Jian, Harris, Estelle, Johnson, Stacy, Paine, Robert, Greene, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009003/
https://www.ncbi.nlm.nih.gov/pubmed/33166179
http://dx.doi.org/10.1513/AnnalsATS.202008-940OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009003/
https://www.ncbi.nlm.nih.gov/pubmed/33166179
http://dx.doi.org/10.1513/AnnalsATS.202008-940OC

Ejemplares similares